Kailera Therapeutics, Inc. (KLRA)
Market Closed
15 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
11. 71
+0.97
+9.0317%
$
1.4B Market Cap
- P/E Ratio
- Div Yield
1.17M Volume
- Eps
$ 10.74
Previous Close 
Want to track KLRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Kailera Therapeutics, Inc. (KLRA) Statistics
Valuation metrics
Market Cap 1.4B
Enterprise value 1.38B
Trailing P/E (ttm) -6.6
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) -
Price/Book (mrq) 1.06
Enterprise Value/Revenue -
Enterprise Value/EBITDA -7.07
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.18M
Average volume (90 days) 894.71K
Price summary
52-Week low 9.76
52-Week high 28.23
Beta -
50-Day moving average 12.34
200-Day moving average 20.98
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.16%
Return on equity -0.55%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 8.97
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 11.11%
Book value per share (mrq) 10.94
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
